Strong performance in the North American market boosts Philips' Q3 comparable sales growth by 3%, adjusted EBITA exceeds expectations
I'm PortAI, I can summarize articles.
Dutch medical technology company Koninklijke Philips N.V. announced its third-quarter results for 2025, with sales declining 2% year-on-year to €4.302 billion, but comparable sales grew by 3%. Comparable sales in North America increased by 5%. Adjusted EBITA was €531 million, exceeding market expectations of €484 million. The CEO stated that the performance reflects investments in the supply chain to mitigate tariff impacts
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments